| |
|
Diagnostic Substances News
|
Immucor to Present at the Piper Jaffray 21st Annual Health Care Conference
Mon 5:23 pm ET (PR Newswire)
Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that access to its presentation at the Piper Jaffray 21st Annual Health Care Conference in New York, NY will be available via a live, simultaneous webcast.
|
| | |
Locate Industry by Company
|
| Market Capitalization: | 11B | | Price
/ Earnings: | 219.3 | | Price
/ Book: | 5.9 | | Net
Profit Margin (mrq): | 2.9% | | Price
To Free Cash Flow (mrq): | -219.3 | | Return
on Equity: | 3.1% | | Total
Debt / Equity: | 0.0 | | Dividend
Yield: | 2.8% |
|